ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Forward Therapeutics at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Forward Therapeutics brings 2 presentations to ACR Convergence 2026 in Orlando. Its program centres on FT2109, an oral TNFR1 signaling inhibitor, covering its preclinical characterization and a first-in-human dose study in healthy participants.

OrganizationACR Convergence 2026 Attendance
Biotech companies
Clinical-stage biotechnology company developing oral small-molecule therapies for inflammation-driven diseases.

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Forward Therapeutics

Tell us what you sell and we’ll find the people at Forward Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction